期刊文献+

人补体片段C5a蛋白的可溶性表达、纯化及生物学活性检测 被引量:1

Soluble Expression,Purification and Bioactivity of Human Complement Fragment C5a Protein
下载PDF
导出
摘要 目的:为得到可溶性表达的人补体片段C5a蛋白,并检测其生物学活性。方法:用IPTG对C5a融合蛋白进行诱导表达,表达产物经肠激酶酶切后用Ni2+分离柱纯化得到C5a蛋白,通过对中性粒细胞的趋化作用、呼吸爆发、产生乳铁蛋白等实验检测C5a蛋白的生物学活性。结果:成功获得可溶性表达的C5a融合蛋白,通过肠激酶酶切后得到高纯度的C5a蛋白,C5a蛋白对人中性粒细胞具有明显的趋化作用,能引起人中性粒细胞的呼吸爆发并能诱导人中性粒细胞产生乳铁蛋白。结论:可溶性表达了具有生物学活性的人补体片段C5a蛋白,为进一步的临床研究和应用奠定了基础。 Objective:To prepare the soluble human complement fragment C5a protein and measure its bioactivity.Methods:The C5a fusion protein was induced to express by IPTG and then digested by enterokinase,purified by Ni2+-NTA column.By the neutrophil chemotaxis,respiratory burst and producing lactoferrin experiment,the bioactivity of C5a protein was be detected.Results:The C5a fusion protein is soluble expression,high purity C5a protein is obtained after the fusion protein be digested by enterokinase.The C5a protein can lead to human neutrophil chemotaxis,cause human neutrophil respiratory burst and induce human neutrophils produce lactoferrin.Conclusion:The human complement fragment C5a protein with bioactivity can be expressed in soluble form.The study laid a foundation for the further clinical research and application.
作者 吕永强
机构地区 解放军第
出处 《中国医药导刊》 2013年第10期1699-1700,共2页 Chinese Journal of Medicinal Guide
关键词 人补体片段C5a蛋白 可溶性表达 生物学活性 Human complement fragment C5a protein Soluble expression Bioactivity
  • 相关文献

参考文献4

二级参考文献57

  • 1Huber-Lang MS,Sarma JV,Zetoune FS,et al.Generation of C5a in the absence of C3:a new complement activation pathway[J].Nat Med,2006,12(6):682-687.
  • 2Guo RF,Ward PA.Role of C5a in inflammatory responses[J].Annu Rev Immunol.2005,23:821-852.
  • 3Manthey HD,Woodruff TM,Taylor SM,et al.Complement component 5a(C5a)[J].Int J Biochem Cell Biol,2009,41(11):2114-2117.
  • 4K(o)hl J.Drug evaluation:The C5a receptor antagonist PMX-53[J].Cur Opin Mol Ther,2006,8(6):529-538.
  • 5Proctor LM,Woodruff TM,Sharma P,et al.Tranadermal pharmacology of smal molecule cyclic C5a antagonists[J].Adv Exp Med Biol,2006,586:329-345.
  • 6Zha X,Tan Z,Chen J,et al.Effects of ropivacaine on adhesion molecule CD11b expression and function in human neutrophils[J].Int Immunopharmacol,2010,10(6):662-667.
  • 7Wang L,Han G,Wang R,et al.Regulation of IL-8 production by complement-activated product,C5a,in vitro and in vivo during sepsis[J].Clin Immunol,2010,137(1):157-165.
  • 8Wrann CD,Winter SW,Barkhausen T,et al.Distinct involvement of p38-,ERK1/2 and PKC signaling pathways in C5a-mediated priming of oxidative burst in phagocytic cells[J].Cell Immunol,2007,245(2):63-69.
  • 9Buhl AM,Osawa S,Johnson GL.Mitogen-activated protein kinase activation requires two signal inputs from the human anaphylatoxin C5a receptor[J].J Biol Chem,1995,270(34):19828-19832.
  • 10Perianayagam MC,Balakrishnan VS,King AJ,et al.C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway[J].Kidney Int,2002,61(2):456-63.

共引文献19

同被引文献11

  • 1夏炎火,姚华国,张媛莉.C5a-C5aR在脓毒症中的作用[J].国际内科学杂志,2007,34(3):184-186. 被引量:1
  • 2Manthey H D, Woodruff T M, Taylor S M,et al.Complement component 5a (C5a) [J], Int J BiochemCell Biol,2009,41(11) :2114-2117.
  • 3Arumugam T V,Magnus T? Woodruff T M, et al.Complement mediators in is chemia- reperfusion in-jury[J]. Clin Chim Acta,2006,374(1) :33-45.
  • 4Woodruff T M,Pollitt S,Proctor L M,et al. Increasedpotency of a novel complement factor 5a receptor an-tagonist in a rat model of inflammatory bowel disease[J], J Pharmacol Exp Ther,2005,314(2) :811-817.
  • 5Woodruff T M,Strachan A J^Dryburgh N,et al. Anti-arthritic activity of an orally active C5a receptor an-tagonist against antigen-induced monarticular arthri-tis in the rat[J]. Arthritis Rheum-US,2002,46 (9):2476-2485.
  • 6Strachan A J, Woodruff T M, Haaima G,et al. A newsmall molecule C5a receptor antagonist inhibits thereverse-passive Arthus reaction and endotoxic shockin rats[J]. J Immunol,2000,164( 12) :6560-6565.
  • 7Woodruff T M,Costantini K J , Taylor S M,et al. Roleof complement in motor neuron disease:animal mod-els and therapeutic potential of complement inhibi-tors[J]. Adv Exp Med Biol,2008,632(13) : 143-158.
  • 8Gerard Huglig T E. Anaphylatoxin from the fifthcomponent of porcine complement [J]. Biol Chem,1979,254(14);6346-6351.
  • 9Hezmeea M N M, Shiels I A, Rolfe B E,et al. Com-plement C5a: impact on the field of veterinary medi-cine[J]. Vet J,2012,192:264-271.
  • 10Gerard C,Hugli 丁 E. Amino Acid Sequence of theAnaphylatoxin from the fifth component of porcinecomplement J ]. Biol Chem, 1980, 255 ( 10 ): 4710-4715.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部